Two years after the appearance of the SARS-CoV-2 virus, the causal agent of the current
global pandemic, it is time to analyze the evolution of the immune protection that infection …

The pandemic coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), is currently the most formidable challenge to …

Background: Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a live attenuated
vaccine mainly administered to newborns and used for over 100 years to prevent the …

Objectives Antiviral adaptive immunity involves memory B cells (MBC) and memory T cells
(MTC). The dynamics of MBC and MTC in severe acute respiratory syndrome coronavirus 2 …

Finding a vaccine that can last a long time and effective against viruses with high mutation
rates such as SARS-CoV-2 is still a challenge today. The various vaccines that have been …

Since December 2019, the world has experienced a nightmare due to the new Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing the deadliest coronavirus …

Background Studies of anti‐SARS‐CoV‐2 humoral and adaptive response in COVID‐19
non‐vaccinated pediatric convalescents are controversial and further evidence from the …

RESUMO Há mais de 3 anos desde o início da pandemia, o vírus SARS-CoV-2 já registrou
mais de 700 milhões de casos cumulativos de infecções com aproximadamente 6 milhões …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the
coronavirus disease 19 (COVID19) pandemic, has imposed a serious public health threat …

ویروس SARS-CoV-2 عامل ایجادکننده پاندمی کووید-19، تهدیدی برای سلامت جامعه جهانی محسوب می
شود که نیازمند درمان های مؤثر و استراتژی های واکسیناسیون جهت کنترل و پیشگیری از این …‎